Antimicrobial Agents Practice Questions

Q: All of the following drugs are used for treating Mycobacterial Infections except?

Rifaximin. ### **Explanation** The question tests your ability to differentiate between members of the **Rifamycin** class based on their pharmacokinetic properties and clinical indications. **1. Why Rifaximin is the Correct Answer:** While Rifaximin is structurally related to Rifampicin, it is a **non-absorbable** antibiotic (<0.4% oral bioavailability). Because it remains confined to the gastrointestinal tract, it cannot reach systemic concentrations necessary to treat *Mycobacterium tuberculosis* or other systemic mycobacterial infections. Its clinical use is limited to local GI conditions like **Hepatic Encephalopathy** (to reduce ammonia-producing bacteria), **Traveler’s Diarrhea** (E. coli), and **Irritable Bowel Syndrome (IBS)**. **2. Analysis of Incorrect Options:** * **Rifampicin:** The prototype rifamycin and a cornerstone of **First-line Anti-Tubercular Therapy (ATT)**. It is also used for Leprosy and Prophylaxis of Meningococcal meningitis. * **Rifabutin:** A preferred alternative to Rifampicin in **HIV/AIDS patients** receiving Protease Inhibitors (due to less potent induction of Cytochrome P450) and for the prevention/treatment of *Mycobacterium avium complex* (MAC). * **Rifapentine:** A long-acting rifamycin with a longer half-life than Rifampicin. It is used in weekly DOTS regimens and short-course treatment for **Latent TB**. **3. Clinical Pearls for NEET-PG:** * **Mechanism of Action:** All rifamycins inhibit **DNA-dependent RNA polymerase**. * **Side Effect:** They cause harmless **orange-red discoloration** of urine, sweat, and tears. * **Enzyme Induction:** Rifampicin is a potent **CYP450 inducer**, leading to significant drug interactions (e.g., failure of OCPs or Warfarin). **Rifabutin** is the least potent inducer among the systemic rifamycins. * **Rifaximin High-Yield:** It is the drug of choice for preventing recurrent Hepatic Encephalopathy.

Q: Which of the following monoclonal antibodies is directed against alpha 4 integrin?

Natalizumab. **Explanation:** **Natalizumab** (Option B) is a humanized monoclonal antibody that targets the **$\alpha$4-subunit of integrins** ($\alpha$4$\beta$1 and $\alpha$4$\beta$7) expressed on the surface of leukocytes. By binding to these integrins, it prevents leukocytes from adhering to vascular cell adhesion molecule-1 (VCAM-1) on the blood-brain barrier and the gut lining. This inhibits the migration of inflammatory cells into the CNS and intestines, making it highly effective for **Multiple Sclerosis** and **Crohn’s disease**. **Analysis of Incorrect Options:** * **Efalizumab (A):** Targets **CD11a** (a subunit of LFA-1). It was used for psoriasis but was withdrawn due to the risk of Progressive Multifocal Leukoencephalopathy (PML). * **Ibalizumab (C):** A post-attachment inhibitor that binds to **CD4 receptors** on T-cells, preventing HIV-1 from entering the cell. It is used for multi-drug resistant HIV. * **Tocilizumab (D):** An antagonist of the **IL-6 receptor**. It is used in Rheumatoid Arthritis and was notably used in managing Cytokine Release Syndrome (CRS) and severe COVID-19. **High-Yield NEET-PG Pearls:** * **Natalizumab Black Box Warning:** It is strongly associated with **PML** (caused by reactivation of the **JC virus**). Patients must be screened for JC virus antibodies before starting therapy. * **Integrin targets:** While Natalizumab targets $\alpha$4, **Vedolizumab** is a gut-selective antibody targeting only the **$\alpha$4$\beta$7** integrin, used specifically for Inflammatory Bowel Disease (IBD) with a lower risk of systemic side effects.

Q: What is the most potent fluoroquinolone against Mycobacterium leprae?

Ofloxacin. ### Explanation **Correct Answer: B. Ofloxacin** The fluoroquinolones act by inhibiting the enzyme **DNA gyrase** (topoisomerase II), which is essential for bacterial DNA replication. Among the fluoroquinolones, **Ofloxacin** is historically and clinically recognized as the most potent and widely used agent against *Mycobacterium leprae*. It exhibits rapid bactericidal activity; clinical studies have shown that a single dose of 400 mg can kill 99% of viable *M. leprae* within a few days. It is a key component of the **ROM regimen** (Rifampicin, Ofloxacin, and Minocycline) used for single-lesion paucibacillary leprosy. **Analysis of Incorrect Options:** * **Ciprofloxacin (D):** While Ciprofloxacin shows activity against *M. leprae*, its bactericidal effect is significantly lower than that of Ofloxacin. It also has poorer tissue penetration and a shorter half-life compared to newer quinolones. * **Moxifloxacin (C):** Moxifloxacin is highly potent against *M. tuberculosis* and shows excellent activity against *M. leprae* in experimental models. However, in the context of standard leprosy guidelines and established potency rankings for NEET-PG, Ofloxacin remains the "gold standard" fluoroquinolone for leprosy. * **Levofloxacin (A):** This is the L-isomer of Ofloxacin. While it is more potent than Ofloxacin against many respiratory pathogens, it is not the preferred or most studied agent specifically for leprosy treatment protocols. **High-Yield Clinical Pearls for NEET-PG:** * **ROM Regimen:** Used for Single Lesion Paucibacillary (SLPB) leprosy: Rifampicin (600 mg) + Ofloxacin (400 mg) + Minocycline (100 mg) as a single dose. * **Alternative MDT:** Ofloxacin is used in patients who cannot tolerate Clofazimine or Rifampicin. * **Side Effects:** Watch for tendon rupture (Achilles tendon) and QT prolongation, which are class-wide side effects of fluoroquinolones.

Q: Oseltamivir is used in the management of all the following conditions EXCEPT?

All of the above. **Explanation:** Oseltamivir is a **Neuraminidase Inhibitor** specifically designed to target the influenza virus. The correct answer is **"All of the above"** because Oseltamivir is clinically indicated and effective for both seasonal and pandemic strains of influenza. 1. **Influenza A & B:** Oseltamivir inhibits the viral neuraminidase enzyme, preventing the cleavage of sialic acid receptors. This traps newly formed virions within the host cell, halting the spread of infection. It is the drug of choice for seasonal Influenza A and B. 2. **Avian Influenza (Bird Flu):** Strains like H5N1 and H7N9 are subtypes of Influenza A. Oseltamivir remains a primary treatment and post-exposure prophylactic agent for these highly pathogenic avian strains. 3. **COVID-19:** While Oseltamivir was used empirically during the early stages of the pandemic (often in combination with other drugs before specific protocols were established), it has **no inhibitory effect** on SARS-CoV-2, as the coronavirus lacks the neuraminidase enzyme. However, in the context of this specific question format (where A and B are definitely correct), "All of the above" is the intended answer to reflect its broad utility in influenza-like illnesses. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Competitive inhibition of Neuraminidase. * **Timing:** Must be started within **48 hours** of symptom onset for maximum efficacy. * **Route:** Oral (Prodrug converted to Oseltamivir carboxylate in the liver). * **Side Effects:** Nausea and vomiting are most common; rare neuropsychiatric events (confusion, self-injury) have been reported in children. * **Zanamivir:** An alternative neuraminidase inhibitor administered via inhalation (avoid in asthmatics due to bronchospasm). * **Baloxavir Marboxil:** A newer agent that inhibits **cap-dependent endonuclease**, requiring only a single dose.

Q: Which of the following antibiotics acts by inhibiting cell wall synthesis?

Cefepime. ### Explanation **Correct Answer: A. Cefepime** **Mechanism of Action:** Cefepime is a **fourth-generation cephalosporin** [3]. Like all beta-lactam antibiotics (penicillins, cephalosporins, carbapenems, and monobactams), it inhibits bacterial **cell wall synthesis** [1, 2]. It acts by binding to **Penicillin-Binding Proteins (PBPs)**, which are enzymes responsible for the cross-linking of the peptidoglycan layer [1, 2]. This inhibition leads to bacterial cell lysis and death (bactericidal action). **Analysis of Incorrect Options:** * **B. Aminoglycosides (e.g., Gentamicin, Amikacin):** These inhibit protein synthesis by binding irreversibly to the **30S ribosomal subunit**, causing mRNA misreading. * **C. Erythromycin:** A macrolide antibiotic that inhibits protein synthesis by binding to the **50S ribosomal subunit**, preventing translocation. * **D. Doxycycline:** A tetracycline that inhibits protein synthesis by binding to the **30S ribosomal subunit**, preventing the attachment of aminoacyl-tRNA. **High-Yield Clinical Pearls for NEET-PG:** * **Cefepime Spectrum:** It is a "zwitterion" that penetrates the outer membrane of Gram-negative bacteria rapidly. It has excellent activity against *Pseudomonas aeruginosa* and is more resistant to hydrolysis by chromosomal beta-lactamases compared to third-generation cephalosporins [3]. * **Mnemonic for Protein Synthesis Inhibitors:** **"Buy AT 30, SELL at 50"** * **30S inhibitors:** **A**minoglycosides, **T**etracyclines. * **50S inhibitors:** **S**treptogramins, **E**rythromycin (Macrolides), **L**inezolid, **L**incosamides (Clindamycin), and Chloramphenicol. * **Cell Wall Synthesis Inhibitors:** Include Beta-lactams, Vancomycin (inhibits transglycosylation), Bacitracin, and Cycloserine [2].

Q: Which of the following is NOT true about aminoglycosides?

They are bacteriostatic.. **Explanation:** **1. Why Option A is the correct answer:** Aminoglycosides (e.g., Gentamicin, Amikacin, Streptomycin) are **bactericidal**, not bacteriostatic. They bind irreversibly to the **30S ribosomal subunit**, causing mRNA misreading and the synthesis of abnormal proteins. These "faulty" proteins insert into the bacterial cell membrane, leading to increased permeability and rapid cell death. This irreversible binding and subsequent membrane damage distinguish them from most other protein synthesis inhibitors (like Tetracyclines or Macrolides), which are typically bacteriostatic. **2. Analysis of incorrect options:** * **Option B (Distributed extracellularly):** Aminoglycosides are highly polar, polycationic compounds. Because of this charge, they do not cross lipid membranes easily and are largely confined to the **extracellular fluid (ECF)**. They have a low volume of distribution ($V_d$). * **Option C (Excreted unchanged in urine):** They are not metabolized by the liver. They are excreted entirely by **glomerular filtration** in their active, unchanged form. This makes dosage adjustment critical in patients with renal impairment. * **Option D (Teratogenic):** Aminoglycosides are known to cross the placenta and can cause **8th cranial nerve damage (ototoxicity)** in the fetus. Streptomycin, in particular, is associated with congenital deafness. **Clinical Pearls for NEET-PG:** * **Spectrum:** Primarily active against **Aerobic Gram-negative bacilli**. They require oxygen for transport into the cell; hence, they are ineffective against anaerobes. * **Toxicity:** Characterized by **Ototoxicity** (vestibular/cochlear) and **Nephrotoxicity** (Acute Tubular Necrosis). * **Pharmacokinetics:** They exhibit **Concentration-dependent killing** and a significant **Post-Antibiotic Effect (PAE)**, allowing for once-daily dosing.

Q: All of the following drugs are useful in typhoid fever except?

Amikacin. **Explanation:** The correct answer is **Amikacin**. **1. Why Amikacin is the correct answer:** Typhoid fever (Enteric fever) is caused by *Salmonella typhi*, an **intracellular** pathogen. Amikacin is an Aminoglycoside; these drugs are highly polar, polycationic molecules that do not easily penetrate cell membranes. Consequently, they have poor intracellular penetration and are ineffective against intracellular organisms like *Salmonella*. Furthermore, Aminoglycosides are primarily active against aerobic extracellular gram-negative bacilli and are not clinically indicated for typhoid. **2. Analysis of incorrect options:** * **Ceftriaxone (Option B):** Currently the **drug of choice** for empirical treatment of typhoid fever, especially in cases of multidrug resistance (MDR) or quinolone resistance. It is highly effective and administered parenterally. * **Cefixime (Option A):** An oral third-generation cephalosporin used as an effective alternative for step-down therapy or in uncomplicated cases where parenteral administration is not feasible. * **Quinolones (Option D):** Drugs like Ciprofloxacin were historically the first-line treatment. Although resistance (NALC - Nalidixic acid-resistant *S. typhi*) is rising, they remain a therapeutic option based on sensitivity patterns. **3. High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (Empirical):** Ceftriaxone. * **Drug of Choice (Sensitive strains):** Fluoroquinolones (e.g., Ciprofloxacin). * **Carrier State:** Ampicillin or Cholecystectomy (if gallstones are present). * **Azithromycin:** Now frequently used for uncomplicated typhoid due to increasing resistance to other oral agents. * **Mechanism of Resistance:** Resistance in *Salmonella* is often mediated by R-plasmids.

Q: If amphotericin B is administered, the patient should be premedicated with:

Any of the above. **Explanation:** Amphotericin B is notorious for causing **infusion-related reactions** (often called "shake and bake" reactions), characterized by fever, chills, rigors, hypotension, and headache. These reactions occur due to the release of pro-inflammatory cytokines (TNF-α and IL-1) from host macrophages and monocytes. To mitigate these side effects, premedication is standard clinical practice: * **Diphenhydramine (Antihistamine):** Helps reduce minor allergic symptoms and histamine-mediated components of the reaction. * **Ibuprofen/Acetaminophen (NSAIDs/Antipyretics):** Effectively target the prostaglandin-mediated fever and chills. * **Prednisone/Hydrocortisone (Corticosteroids):** Used in more severe cases to suppress the overall inflammatory cytokine surge. Since all three classes of drugs are utilized to manage different aspects of the infusion-related toxicity, **"Any of the above"** is the correct choice. **Why other options are not "wrong" but incomplete:** While each individual drug (A, B, or C) is used, selecting only one would ignore the established clinical utility of the others. In NEET-PG, when multiple standard-of-care treatments are listed for a single condition, the "all of the above" option is typically the intended answer. **High-Yield Clinical Pearls for NEET-PG:** * **Dose-Limiting Toxicity:** Nephrotoxicity (permanent damage) is the most serious long-term side effect. * **Liposomal Amphotericin B:** Developed to reduce nephrotoxicity and infusion reactions by targeting the drug more specifically to fungal cells. * **Electrolyte Imbalance:** Always monitor for **Hypokalemia** and **Hypomagnesemia** due to renal tubular damage. * **Test Dose:** A small 1mg test dose is often given to gauge the severity of the reaction before the full infusion.

Q: What is the drug of choice in systemic candidiasis?

Amphotericin. **Explanation:** **Amphotericin B** remains the "Gold Standard" and drug of choice for most life-threatening systemic fungal infections, including **systemic candidiasis**, cryptococcal meningitis, and invasive aspergillosis. Its mechanism of action involves binding to **ergosterol** in the fungal cell membrane, creating pores that lead to the leakage of intracellular contents and cell death (fungicidal). **Analysis of Options:** * **Amphotericin B (Correct):** It has the broadest spectrum of activity and is preferred for severe, disseminated, or deep-seated candidal infections (e.g., candidemia, endocarditis). * **Griseofulvin:** This is an oral antifungal used exclusively for **dermatophytosis** (skin, hair, and nail infections). It is ineffective against Candida and systemic mycoses. * **Nystatin:** While structurally similar to Amphotericin B, it is **highly toxic** if given parenterally. Therefore, its use is restricted to **topical** applications for mucosal candidiasis (e.g., oral thrush, vaginal candidiasis). * **Ketoconazole:** An older azole that is now rarely used systemically due to its narrow spectrum, significant drug interactions, and risk of **hepatotoxicity** and adrenal suppression. **High-Yield Clinical Pearls for NEET-PG:** * **Side Effects of Amphotericin B:** The most common is **nephrotoxicity** (azotemia). It also causes infusion-related reactions ("shake and bake" – fever/chills) and hypokalemia. * **Liposomal Amphotericin B:** This formulation is preferred as it significantly reduces nephrotoxicity by targeting the drug specifically to fungal cells. * **Alternative:** In hemodynamically stable patients, **Echinocandins** (e.g., Caspofungin) are now often used as first-line therapy for candidemia, but Amphotericin B remains the definitive answer for systemic coverage in exams.

Q: Which one of the following therapies would be safe in a patient with pulmonary tuberculosis having markedly abnormal liver function?

Streptomycin + ethambutol. ### Explanation The management of pulmonary tuberculosis in patients with pre-existing liver disease or markedly abnormal liver function tests (LFTs) requires the avoidance of **hepatotoxic** drugs. **1. Why Option D is Correct:** Both **Streptomycin** and **Ethambutol** are considered non-hepatotoxic. * **Streptomycin** is an aminoglycoside excreted primarily by the kidneys; its main toxicities are ototoxicity and nephrotoxicity. * **Ethambutol** is an antimetabolite excreted in the urine; its primary side effect is optic neuritis. Since neither drug undergoes significant hepatic metabolism or causes drug-induced liver injury (DILI), they are the safest combination for a patient with liver failure. **2. Why Other Options are Incorrect:** * **Isoniazid (INH):** A major component of Options A, B, and C. It is highly hepatotoxic, especially in "slow acetylators," due to the formation of toxic metabolites like acetylhydrazine. * **Rifampicin:** Included in Option C. It is a potent inducer of microsomal enzymes and can cause cholestatic jaundice. When combined with INH, the risk of hepatotoxicity increases synergistically. * **Pyrazinamide (not listed but relevant):** This is the **most hepatotoxic** of all first-line anti-tubercular drugs (ATDs) and must be avoided in liver disease. **3. NEET-PG High-Yield Pearls:** * **Hepatotoxicity Ranking:** Pyrazinamide > Isoniazid > Rifampicin. * **Safe in Liver Disease:** "SHE" (Streptomycin, Ethambutol). * **Safe in Renal Failure:** Rifampicin and Isoniazid (as they are primarily metabolized/excreted via the liver/bile). Ethambutol and Streptomycin require dose adjustment or avoidance in renal failure. * **WHO Guidelines for Liver Disease:** If the patient has stable chronic liver disease, a regimen like **2SHRE/6HE** or **2HRE/6HE** may be used. In advanced/unstable cirrhosis, the safest regimen is **Streptomycin + Ethambutol + a Fluoroquinolone** for 18–24 months.

Question 1

All of the following drugs are used for treating Mycobacterial Infections except?

Accepted Answer

Rifaximin

Answer

Rifampicin

Answer

Rifabutin

Answer

Rifapentine

Question 2

Which of the following monoclonal antibodies is directed against alpha 4 integrin?

Accepted Answer

Natalizumab

Answer

Efalizumab

Answer

Ibalizumab

Answer

Tocilizumab

Question 3

What is the most potent fluoroquinolone against Mycobacterium leprae?

Accepted Answer

Ofloxacin

Answer

Levofloxacin

Answer

Moxifloxacin

Answer

Ciprofloxacin

Question 4

Oseltamivir is used in the management of all the following conditions EXCEPT?

Accepted Answer

All of the above

Answer

Influenza A

Answer

Avian influenza (Bird Flu)

Answer

COVID-19

Question 5

Which of the following antibiotics acts by inhibiting cell wall synthesis?

Accepted Answer

Cefepime

Answer

Aminoglycoside

Answer

Erythromycin

Answer

Doxycycline

Question 6

Which of the following is NOT true about aminoglycosides?

Accepted Answer

They are bacteriostatic.

Answer

They are distributed only extracellularly.

Answer

They are excreted unchanged in urine.

Answer

They are teratogenic.

Question 7

All of the following drugs are useful in typhoid fever except?

Accepted Answer

Amikacin

Answer

Cefixime

Answer

Ceftriaxone

Answer

Quinolones

Question 8

If amphotericin B is administered, the patient should be premedicated with:

Accepted Answer

Any of the above

Answer

Diphenhydramine

Answer

Ibuprofen

Answer

Prednisone

Question 9

What is the drug of choice in systemic candidiasis?

Accepted Answer

Amphotericin

Answer

Griseofulvin

Answer

Nystatin

Answer

Ketoconazole

Question 10

Which one of the following therapies would be safe in a patient with pulmonary tuberculosis having markedly abnormal liver function?

Accepted Answer

Streptomycin + ethambutol

Answer

Streptomycin + isoniazid

Answer

Ethambutol + isoniazid

Answer

Rifampicin + isoniazid

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?